Lymphomas with pseudo–double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations-Reference-Cited by-同舟云学术

Lymphomas with pseudo–double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations

Published:2018-10 Issue: Volume:80 Page:192-200
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Johnson Steven M.,Umakanthan Jayadev Manikkam,Yuan Ji,Fedoriw Yuri,Bociek R. Gregory,Kaiser-Rogers Kathleen,Sanmann Jennifer N.,Montgomery Nathan D.

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference35 articles.

1. Review article Double-hit B-cell lymphomas;Aukema;Hematology,2011

2. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma;Rosenthal;Blood Rev,2017

3. The prognosis of MYC translocation positive diffuse large B-cell lymphoma depends on the second hit;Clipson;J Pathol Clin Res,2015

4. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas;Bertrand;Leukemia,2007

5. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: A GELA/LYSA study;Copie-Bergman;Blood,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics and Clinical Value of MYC, BCL2, and BCL6 Rearrangement Detected by Next-generation Sequencing in DLBCL;American Journal of Surgical Pathology;2024-06-28

2. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement;BMJ Case Reports;2024-06

3. Cytogenetic and pathologic characterization of MYC-rearranged B-cell lymphomas in pediatric and young adult patients;Journal of Hematopathology;2024-04-02

4. New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?;Journal of Clinical Medicine;2024-03-27

5. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential;Leukemia;2024-01-06